4 Results for "

entrectinib

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "entrectinib" in MCE Product Catalog:

31
31 Cited Publications
Cat. No.: HY-12678
CAS No.: 1108743-60-7
Purity:  99.79%
Synonyms: NMS-E628; RXDX-101
Entrectinib (NMS-E628) is an orally active, BBB-penetrated and centrally active inhibitor of TrkA/B/C, ROS1 and ALK, with IC50 values of 1, 3, 5, 12 and 7 nM, respectively. Entrectinib induces apoptosis and cycle arrest in cancer cells, has antitumor activity, and attenuates bleomycin-induced lung fibrosis in mice .
loading...
    loading...
Cat. No.: HY-12678S1
CAS No.: 2251773-94-9
Purity:  99.82%
Synonyms: NMS-E628-d8; RXDX-101-d8
Entrectinib-d8 (NMS-E628-d8; RXDX-101-d8) is a deuterated version of Entrectinib (HY-12678). Entrectinib (NMS-E628) is an orally available, blood-brain barrier permeable, central nervous system active TrkA/B/C, ROS1 and ALK inhibitor with IC50 values of 1, 3, 5, 12 and 12, respectively. 7 nM. Entrectinib induces apoptosis and cycle arrest in cancer cells, has anti-tumor activity, and also alleviates bleomycin-induced pulmonary fibrosis in mice .
loading...
    loading...
Cat. No.: HY-12678R
CAS No.: 1108743-60-7
Synonyms: NMS-E628 (Standard); RXDX-101 (Standard)
Entrectinib (Standard) is the analytical standard of Entrectinib. This product is intended for research and analytical applications. Entrectinib (NMS-E628) is an orally active, BBB-penetrated and centrally active inhibitor of TrkA/B/C, ROS1 and ALK, with IC50 values of 1, 3, 5, 12 and 7 nM, respectively. Entrectinib induces apoptosis and cycle arrest in cancer cells, has antitumor activity, and attenuates bleomycin-induced lung fibrosis in mice .
loading...
    loading...
Cat. No.: HY-12678S
Synonyms: NMS-E628-d4; RXDX-101-d4
Entrectinib-d4 (NMS-E628-d4; RXDX-101-d4) is the deuterium labeled Entrectinib (HY-12678). Entrectinib is an orally active, BBB-penetrated and centrally active inhibitor of TrkA/B/C, ROS1 and ALK, with IC50 values of 1, 3, 5, 12 and 7 nM, respectively. Entrectinib induces apoptosis and cycle arrest in cancer cells, has antitumor activity, and attenuates bleomycin-induced lung fibrosis in mice .
loading...
    loading...